The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)

被引：1
|
作者：
Boi, Michela [1 ]
Bonetti, Paola [1 ]
Ponzoni, Maurilio [2 ,3 ]
Tibiletti, Maria Grazia [4 ]
Stathis, Anastasios [5 ]
Cvitkovic, Esteban [6 ]
Inghirami, Giorgio [7 ]
Zucca, Emanuele [5 ]
Bertoni, Francesco [8 ]
机构：
[1] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[2] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Unit Lymphoid Malignancies, I-20132 Milan, Italy
[4] Insubria Univ, Varese, Italy
[5] IOSI Oncol Inst So Switzerland, Bellinzona, Switzerland
[6] OncoEthix SA, Lausanne, Switzerland
[7] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy
[8] Oncol Inst So Switzerland IOSI, Lymphoma Unit, Bellinzona, Switzerland
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4872.4872
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4872
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The BRD-inhibitor OTX015 Shows Pre-clinical Activity in Diffuse Large B-cell Lymphoma (DLBCL)
    Bonetti, P.
    Ponzoni, M.
    Tibiletti, M. G.
    Stathis, A.
    Heirat, P.
    Zucca, E.
    Bertoni, F.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 163 - 163
  • [2] The Brd-Inhibitor OTX015 Is Active in Pre-Clinical Models of Mature B-Cell Lymphoid Tumors
    Bonetti, Paola
    Boi, Michela
    Ponzoni, Maurilio
    Tibiletti, Maria Grazia
    Stahis, Anastasios
    Inghirami, Giorgio
    Noel, Kay
    Zucca, Emanuele
    Bertoni, Francesco
    BLOOD, 2012, 120 (21)
  • [3] OTX015, a bromodomain and extraterminal inhibitor, represents a novel agent for ALK positive anaplastic large cell lymphoma
    Boi, Michela
    Todaro, Maria
    Vurchio, Valentina
    Cvitkovic, Esteban
    Riveiro, Eugenia
    Bertoni, Francesco
    Inghirami, Giorgio
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [4] The BET Bromodomain inhibitor OTX015 targets the NFKB, TLR and JAK/STAT pathways and shows pre-clinical activity as single agent and in combination in mature B-cell tumors
    Gaudio, Eugenio
    Bernasconi, Elena
    Kwee, Ivo
    Boi, Michela
    Bonetti, Paola
    Tarantelli, Chiara
    Rinaldi, Andrea
    Testoni, Monica
    Ponzoni, Maurilio
    Stathis, Anastasios
    Stuessi, Georg
    Riveiro, Eugenia
    Herait, Patrice
    Zucca, Emanuele
    Bertoni, Francesco
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
    Gaudio, Eugenio
    Tarantelli, Chiara
    Ponzoni, Maurilio
    Odore, Elodie
    Rezai, Keyvan
    Bernasconi, Elena
    Cascione, Luciano
    Rinaldi, Andrea
    Stathis, Anastasios
    Riveiro, Eugenia
    Cvitkovic, Esteban
    Zucca, Emanuele
    Bertoni, Francesco
    ONCOTARGET, 2016, 7 (36) : 58142 - 58147
  • [6] Pre-Clinical Activity of Tipifarnib in Cutaneous T-Cell Lymphoma
    Johnson, William
    Kohnken, Rebecca
    McNeil, Betina
    Wen, Jing
    McConnell, Kathleen
    Basem, William
    Burrows, Francis
    Porcu, Pierluigi
    Mishra, Anjali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S283 - S284
  • [7] Pre-clinical evaluation of ceritinib in anaplastic large cell lymphoma
    Ganguly, Siddhartha
    Kuravi, Sudhakiranmayi
    Alleboina, Satyanarayana
    Weckbaugh, Brandon
    Satelli, Deepti
    Roy, Jensen
    Weir, Scott
    McGuirk, Joseph
    Balusu, Ramesh
    CANCER RESEARCH, 2015, 75
  • [8] The BET Inhibitor OTX015 (MK-8628) Shows in Vivo Antitumor Activity in Combination with Additional Targeted Agents in Diffuse Large B-Cell Lymphoma (DLBCL)
    Gaudio, Eugenio
    Cascione, Luciano
    Ponzoni, Maurilio
    Tarantelli, Chiara
    Bernasconi, Elena
    Riveiro, Maria Eugenia
    Cvitkovic, Esteban
    Zucca, Emanuele
    Bertoni, Francesco
    BLOOD, 2015, 126 (23)
  • [9] BET Bromodomain Inhibitor OTX015 Affects the Expression of Micrornas Involved in the Pathogenesis of Diffuse Large B-Cell Lymphoma
    Cascione, Luciano
    Gaudio, Eugenio
    Bernasconi, Elena
    Tarantelli, Chiara
    Rinaldi, Andrea
    Testoni, Monica
    Bomben, Riccardo
    Gattei, Valter
    Kwee, Ivo
    Stathis, Anastasios
    Riveiro, Maria Eugenia
    Zucca, Emanuele
    Bertoni, Francesco
    BLOOD, 2014, 124 (21)
  • [10] Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
    Boi, Michela
    Todaro, Maria
    Vurchio, Valentina
    Yang, Shao Ning
    Moon, John
    Kwee, Ivo
    Rinaldi, Andrea
    Pan, Heng
    Crescenzo, Ramona
    Cheng, Mangeng
    Cerchietti, Leandro
    Elemento, Olivier
    Riveiro, Maria E.
    Cvitkovic, Esteban
    Bertoni, Francesco
    Inghirami, Giorgio
    ONCOTARGET, 2016, 7 (48) : 79623 - 79639
12345